Fritextsökning
Innehållstyper
-
Identitetskris i intresseorganisationer?
-
Ökade vårdkostnader i Europa kräver långsiktiga satsningar på innovation
Anna Nilsson Vindefjärd, Generalsekreterare på Forska Sverige.
-
Osäkert om Sverige har vad som krävs
Framtidens sjukvård ligger i gränssnittet mellan medicin och it, enligt en rapport från Life Science Foresight Institute i Lund. Men det är osäkert om svensk industri har tillräckligt med resurser för att vara med i matchen....
-
Nya EU-regler påverkar life science-branschen
Stora regulatoriska förändringar på gång i EU.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Platform for high security virus purification
Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a ...
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Mediciner i svenska vatten en hälsofara
Även de låga halter av olika läkemedel som finns i svenska vattendrag ökar inflammationen i mänskliga celler.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...
-
Trögt för medtech
En svag tillväxt, färre men större förvärv och rekordmånga börsnoteringar är några av fynden i konsultbolaget EY:s årliga sammanställning av medtechbranschen.
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Bäst effekt om datorn får bestämma
Individanpassade läkemedel helt utvecklade i datorn, det är en verklighet som kan vara sann om tio år, tror Jens Nielsen, professor i systembiologi på Chalmers i Göteborg.